Evotec SE (EVO) Net Cash Flow (QoQ) (2009 - 2026)
Evotec SE (EVO) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.03% |
| Dec 31, 2025 | 143,156.16% |
| Sep 30, 2025 | -790.42% |
| Jun 30, 2025 | 39.67% |
| Mar 31, 2025 | 99.99% |
| Dec 31, 2024 | -2,194,036.44% |
| Sep 30, 2024 | 104.82% |
| Jun 30, 2024 | -134.23% |
| Mar 31, 2024 | -100.09% |
| Dec 31, 2023 | 194,095.51% |
| Sep 30, 2023 | 93.85% |
| Jun 30, 2023 | 188.99% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | -113,087.32% |
| Sep 30, 2022 | -983.08% |
| Jun 30, 2022 | 164.42% |
| Mar 31, 2022 | -100.01% |
| Dec 31, 2021 | 407,850.20% |
| Sep 30, 2021 | -51.26% |
| Jun 30, 2021 | 637.50% |